In a surprise Hans Bishop takes over as CEO of Grail the liquid biopsy startup

In a surprise, Hans Bishop takes over as CEO of Grail, the liquid biopsy startup

Grail, the San Francisco company trying to develop a blood test to detect cancer, said it had appointed Hans Bishop, previously the CEO of Juno Therapeutics, as its new CEO

More From BioPortfolio on "In a surprise, Hans Bishop takes over as CEO of Grail, the liquid biopsy startup"